159 related articles for article (PubMed ID: 34861944)
41. Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases.
Boyer PL; Julias JG; Marquez VE; Hughes SH
J Mol Biol; 2005 Jan; 345(3):441-50. PubMed ID: 15581889
[TBL] [Abstract][Full Text] [Related]
42. Non-nucleoside inhibitors of herpesviruses.
Wathen MW
Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
[TBL] [Abstract][Full Text] [Related]
43. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
Hwang YT; Smith JF; Gao L; Hwang CB
Virology; 1998 Jul; 246(2):298-305. PubMed ID: 9657948
[TBL] [Abstract][Full Text] [Related]
44. Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra.
Topalis D; Gillemot S; Snoeck R; Andrei G
Drug Resist Updat; 2018 Mar; 37():1-16. PubMed ID: 29548479
[TBL] [Abstract][Full Text] [Related]
45. Understanding the molecular basis of HBV drug resistance by molecular modeling.
Sharon A; Chu CK
Antiviral Res; 2008 Dec; 80(3):339-53. PubMed ID: 18765256
[TBL] [Abstract][Full Text] [Related]
46. Guanine α-carboxy nucleoside phosphonate (G-α-CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes viruses.
Balzarini J; Menni M; Das K; van Berckelaer L; Ford A; Maguire NM; Liekens S; Boehmer PE; Arnold E; Götte M; Maguire AR
Biochem Pharmacol; 2017 Jul; 136():51-61. PubMed ID: 28390939
[TBL] [Abstract][Full Text] [Related]
47. Herpes simplex virus resistance to antiviral drugs.
Morfin F; Thouvenot D
J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
[TBL] [Abstract][Full Text] [Related]
48. Evaluating phenotype and genotype of drug-resistant strains in herpesviruses.
Andrei G; Fiten P; De Clercq E; Snoeck R; Opdenakker G
Mol Biotechnol; 2001 Jun; 18(2):155-67. PubMed ID: 11471457
[TBL] [Abstract][Full Text] [Related]
49. Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.
Coen N; Duraffour S; Topalis D; Snoeck R; Andrei G
Antimicrob Agents Chemother; 2014 Dec; 58(12):7312-23. PubMed ID: 25267682
[TBL] [Abstract][Full Text] [Related]
50. Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties.
Deville-Bonne D; El Amri C; Meyer P; Chen Y; Agrofoglio LA; Janin J
Antiviral Res; 2010 Apr; 86(1):101-20. PubMed ID: 20417378
[TBL] [Abstract][Full Text] [Related]
51. Presteady state kinetic investigation of the incorporation of anti-hepatitis B nucleotide analogues catalyzed by noncanonical human DNA polymerases.
Brown JA; Pack LR; Fowler JD; Suo Z
Chem Res Toxicol; 2012 Jan; 25(1):225-33. PubMed ID: 22132702
[TBL] [Abstract][Full Text] [Related]
52. Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers.
Ehlers B; Borchers K; Grund C; Frölich K; Ludwig H; Buhk HJ
Virus Genes; 1999; 18(3):211-20. PubMed ID: 10456789
[TBL] [Abstract][Full Text] [Related]
53. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
54. Characterization of an aphidicolin-resistant mutant of herpes simplex virus type 2 which induces an altered viral DNA polymerase.
Nishiyama Y; Suzuki S; Yamauchi M; Maeno K; Yoshida S
Virology; 1984 May; 135(1):87-96. PubMed ID: 6328755
[TBL] [Abstract][Full Text] [Related]
55. Distinctive properties of DNA polymerases induced by herpes simplex virus type-1 and Epstein-Barr virus.
Allaudeen HS
Antiviral Res; 1985 Feb; 5(1):1-12. PubMed ID: 2984987
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
[TBL] [Abstract][Full Text] [Related]
57. Poxviruses Bearing DNA Polymerase Mutations Show Complex Patterns of Cross-Resistance.
Andrei G; Fiten P; Krečmerová M; Opdenakker G; Topalis D; Snoeck R
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327382
[TBL] [Abstract][Full Text] [Related]
58. Quantification of pyrophosphate as a universal approach to determine polymerase activity and assay polymerase inhibitors.
Malvezzi S; Sturla SJ; Tanasova M
Anal Biochem; 2015 Jun; 478():1-7. PubMed ID: 25772306
[TBL] [Abstract][Full Text] [Related]
59. Incorporation of 5-substituted analogs of deoxycytidine into DNA of herpes simplex virus-infected or - transformed cells without deamination to the thymidine analog.
Fox L; Dobersen MJ; Greer S
Antimicrob Agents Chemother; 1983 Mar; 23(3):465-76. PubMed ID: 6303214
[TBL] [Abstract][Full Text] [Related]
60. Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain.
Gibbs JS; Chiou HC; Hall JD; Mount DW; Retondo MJ; Weller SK; Coen DM
Proc Natl Acad Sci U S A; 1985 Dec; 82(23):7969-73. PubMed ID: 2999787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
